Os acordos exclusion payment entre empresas de medicamentos de referência e de genéricos:: práticas restritivas da concorrência?
The conclusion of agreements between reference medicines and generic companies, especially in the United States, became frequent and usual anti-competitive practice, with more applicants than in the EU and Brazil. Among the most common settings and supposedly deleterious competition, we highlight th...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | Portugalera |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://dialnet.unirioja.es/servlet/oaiart?codigo=6723864 |
| Baliabidea: | PIDCC: Revista em propriedade intelectual direito contêmporaneo, ISSN 2316-8080, Nº. 8, 2014, pags. 392-420 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe: Izan zaitez lehena erregistro honi etiketa jartzen
|